176 related articles for article (PubMed ID: 27178543)
1. The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca(2+) signalling in steatotic hepatocytes.
Ali ES; Hua J; Wilson CH; Tallis GA; Zhou FH; Rychkov GY; Barritt GJ
Biochim Biophys Acta; 2016 Sep; 1863(9):2135-46. PubMed ID: 27178543
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Disorders and Cancer: Hepatocyte Store-Operated Ca
Ali ES; Rychkov GY; Barritt GJ
Adv Exp Med Biol; 2017; 993():595-621. PubMed ID: 28900935
[TBL] [Abstract][Full Text] [Related]
3. Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase C-dependent mechanism.
Wilson CH; Ali ES; Scrimgeour N; Martin AM; Hua J; Tallis GA; Rychkov GY; Barritt GJ
Biochem J; 2015 Mar; 466(2):379-90. PubMed ID: 25422863
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.
Chen-Liaw AY; Hammel G; Gomez G
In Vitro Cell Dev Biol Anim; 2017 Sep; 53(8):721-727. PubMed ID: 28707223
[TBL] [Abstract][Full Text] [Related]
5. Impaired Ca
Ali ES; Girard D; Petrovsky N
Am J Physiol Cell Physiol; 2021 Jul; 321(1):C187-C198. PubMed ID: 34106786
[TBL] [Abstract][Full Text] [Related]
6. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.
Sharma S; Mells JE; Fu PP; Saxena NK; Anania FA
PLoS One; 2011; 6(9):e25269. PubMed ID: 21957486
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
Ding X; Saxena NK; Lin S; Gupta NA; Anania FA
Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859
[TBL] [Abstract][Full Text] [Related]
8. Deranged hepatocyte intracellular Ca
Ali ES; Rychkov GY; Barritt GJ
Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
10. SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.
Zheng X; Xu F; Liang H; Cao H; Cai M; Xu W; Weng J
Hepatology; 2017 Sep; 66(3):809-824. PubMed ID: 28439947
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.
Gupta NA; Mells J; Dunham RM; Grakoui A; Handy J; Saxena NK; Anania FA
Hepatology; 2010 May; 51(5):1584-92. PubMed ID: 20225248
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect.
Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
Pharmacol Rep; 2012; 64(1):140-9. PubMed ID: 22580530
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism.
Lee J; Hong SW; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
Cell Stress Chaperones; 2014 Sep; 19(5):649-56. PubMed ID: 24446069
[TBL] [Abstract][Full Text] [Related]
15. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
16. Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.
Alcántara AI; Morales M; Delgado E; López-Delgado MI; Clemente F; Luque MA; Malaisse WJ; Valverde I; Villanueva-Peñacarrillo ML
Arch Biochem Biophys; 1997 May; 341(1):1-7. PubMed ID: 9143346
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
[TBL] [Abstract][Full Text] [Related]
18. Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes.
Lyu J; Imachi H; Fukunaga K; Sato S; Kobayashi T; Dong T; Saheki T; Matsumoto M; Iwama H; Zhang H; Murao K
Mol Metab; 2020 Apr; 34():16-26. PubMed ID: 32180556
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice.
Lee J; Hong SW; Chae SW; Kim DH; Choi JH; Bae JC; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Kim SW; Lee WY
PLoS One; 2012; 7(2):e31394. PubMed ID: 22363635
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
